In a bold — and necessary — move, the editors of four of the biggest medical journals are taking a stand and demanding the guaranteed scientific independence of researchers who publish drug company-sponsored clinical studies. It’s a tricky realm in which to tread. Big pharmaceuticals have become the largest funder of scientific research, and to lose that source of funding would be a big hit to American biomedical research… that being said, corporate self-interest should not be able to dictate which medications make it onto the market in the U.S., and which are put on the market despite evidence of their failure.

About dang time, says I.